AOD-9604 vs hGH Fragment 176-191
Both are categorized under Fat metabolism in our directory—here is how they differ in name, use, and label context.
Both are categorized under Fat metabolism in our directory—here is how they differ in name, use, and label context.
PubMed paper counts, ClinicalTrials.gov listings, and regulatory context—aggregated from public databases.
Fat metabolism
A fragment of human growth hormone studied for fat loss without IGF-1 effects.
AOD-9604 is the C-terminal fragment of hGH (amino acids 176–191). Trials explored fat reduction without growth effects; results were modest. WADA-prohibited. Sold as a research peptide for body recomposition—evidence…
Fat metabolism
The lipolytic piece of growth hormone—marketed for fat loss in research markets.
This region of growth hormone is thought to drive fat metabolism without full GH side effects. Clinical development stalled; most use is gray-market injection. Often confused with or sold alongside AOD-9604.…
Both are categorized under Fat metabolism in our directory—here is how they differ in name, use, and label context. AOD-9604 is categorized as Fat metabolism; hGH Fragment 176-191 as Fat metabolism. AOD-9604: A fragment of human growth hormone studied for fat loss without IGF-1 effects. hGH Fragment 176-191: The lipolytic piece of growth hormone—marketed for fat loss in research markets.
No. They are different molecules with distinct names on labels and in research databases. Always match the full INCI or drug name—not a nickname on the front of the package.
Neither page is medical or anti-doping advice. Research peptides discussed in fitness communities may be prohibited in tested sport or unavailable as OTC supplements. Verify WADA lists and talk to a clinician.